Loading...

RLYB RALLYBIO CORP Management Changes 8-K Filing

RLLY

RLYB

RALLYBIO CORP

(RLYB)

2026 8-K

Merger Announcement

Merger Termination Fee

Management Departure

Stock Split Approved

Financial Results

Nasdaq Transfer Update

Financial Statements

Asset Acquisitions

Financial Statements

Product Discontinuation

Stock Sale Amendment

Financial Results

Nasdaq Notification

Financial Results

Director Resignation

Financial Results Announcement

Resignation of Executive Ch...

Annual Meeting of Shareholders

Earnings Reports

Collaboration Agreement and...

Financial Results Announcement

Workforce Reduction and Est...

Phase 1 Data Announcement

Earnings Reports

Earnings Reports

Management Changes

Annual Meeting Results

Earnings Reports

Financial Results and Clini...

Appointment of New Chief Fi...

External Links:

On March 31, 2026, Rallybio Corp announced the immediate departure of Chief Medical Officer Steven Ryder, who will receive severance benefits as per his agreement, particularly linked to the company's merger with Candid Therapeutics.

AI Assistant

RALLYBIO CORP

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.